USANA Health Sciences, Inc.
Hedge Funds Holdings
Last updated:
USANA Health Sciences, Inc.‘s stocks are currently a part of 149 hedge funds’ portfolios, which represents 49.03% of the total amount of its stocks outstanding. This makes up a total of 9.43M shares of USANA Health Sciences, Inc.. Compared to the previous quarter, the number fell by -9.04% or -938.19K shares fewer. As for the holding position changes, 34.23% (51) of current hedge fund investors increased the number of shares held, 44.97% (67) of current holders sold a part of the shares held, and 15.44% (23) closed the holdings completely. 13 hedge funds are new holders of USANA Health Sciences, Inc. stock in Q3 2022, it is 8.72% of total holders.
Hedge funds holding USANA Health Sciences (Q4 2017 – Q3 2022)
| Q4 2017 | 148 |
|---|---|
| Q1 2018 | 165 |
| Q2 2018 | 185 |
| Q3 2018 | 194 |
| Q4 2018 | 187 |
| Q1 2019 | 185 |
| Q2 2019 | 169 |
| Q3 2019 | 163 |
| Q4 2019 | 169 |
| Q1 2020 | 165 |
| Q2 2020 | 188 |
| Q3 2020 | 189 |
| Q4 2020 | 187 |
| Q1 2021 | 196 |
| Q2 2021 | 186 |
| Q3 2021 | 176 |
| Q4 2021 | 185 |
| Q1 2022 | 167 |
| Q2 2022 | 175 |
| Q3 2022 | 149 |
Hedge funds changes in USANA Health Sciences positions (Q4 2017 – Q3 2022)
| Q4 2017 | 24 | 50 | 51 | 15 | 8 |
|---|---|---|---|---|---|
| Q1 2018 | 32 | 54 | 49 | 13 | 17 |
| Q2 2018 | 45 | 67 | 50 | 22 | 1 |
| Q3 2018 | 31 | 64 | 72 | 20 | 7 |
| Q4 2018 | 22 | 54 | 84 | 28 | -1 |
| Q1 2019 | 36 | 72 | 52 | 38 | -13 |
| Q2 2019 | 30 | 51 | 67 | 43 | -22 |
| Q3 2019 | 29 | 44 | 71 | 35 | -16 |
| Q4 2019 | 32 | 36 | 73 | 20 | 8 |
| Q1 2020 | 31 | 51 | 50 | 31 | 2 |
| Q2 2020 | 37 | 54 | 71 | 15 | 11 |
| Q3 2020 | 25 | 58 | 75 | 22 | 9 |
| Q4 2020 | 16 | 61 | 69 | 19 | 22 |
| Q1 2021 | 32 | 59 | 69 | 20 | 16 |
| Q2 2021 | 16 | 62 | 70 | 25 | 13 |
| Q3 2021 | 17 | 55 | 67 | 25 | 12 |
| Q4 2021 | 27 | 34 | 90 | 19 | 15 |
| Q1 2022 | 14 | 70 | 57 | 26 | 0 |
| Q2 2022 | 23 | 62 | 66 | 14 | 10 |
| Q3 2022 | 13 | 51 | 67 | 23 | -5 |
Hedge funds changes in USANA Health Sciences stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 1,534,000 | 2,726,000 |
|---|---|---|
| Q1 2018 | 284,000 | 1,024,000 |
| Q2 2018 | 899,000 | 1,639,000 |
| Q3 2018 | 1,049,000 | 1,411,000 |
| Q4 2018 | 294,000 | 2,648,000 |
| Q1 2019 | 1,319,000 | 1,015,000 |
| Q2 2019 | 1,931,000 | 29,128,000 |
| Q3 2019 | 1,047,000 | 1,396,000 |
| Q4 2019 | 800,000 | 17,744,000 |
| Q1 2020 | 805,000 | 13,369,000 |
| Q2 2020 | 910,000 | 1,873,000 |
| Q3 2020 | 758,000 | 353,000 |
| Q4 2020 | 477,000 | 593,000 |
| Q1 2021 | 1,015,000 | 1,453,000 |
| Q2 2021 | 614,000 | 1,311,000 |
| Q3 2021 | 841,000 | 2,103,000 |
| Q4 2021 | 0 | 486,000 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 22,000 | 39,000 |